Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Anti-N-methyl-d-aspartate receptor encephalitis in an older patient presenting with a rapid onset of delusions and amnesia.

Marinova Z, Bausch-Becker N, Savaskan E.

BMJ Case Rep. 2019 Apr 15;12(4). pii: e228512. doi: 10.1136/bcr-2018-228512.

PMID:
30992284
2.

Benzodiazepines and/or neuroleptics for the treatment of delirium in palliative care?-a critical appraisal of recent randomized controlled trials.

Gaertner J, Eychmueller S, Leyhe T, Bueche D, Savaskan E, Schlögl M.

Ann Palliat Med. 2019 Mar 26. pii: apm.2019.03.06. doi: 10.21037/apm.2019.03.06. [Epub ahead of print]

3.

[The Physical Examination of an 'Uncooperative' Elderly Patient].

Schlögl M, Schietzel S, Kunz R, Savaskan E, Kressig RW, Riese F.

Praxis (Bern 1994). 2018 Sep;107(19):1021-1030. doi: 10.1024/1661-8157/a003038. German.

PMID:
30227797
4.

Memory deficits for facial identity in patients with amnestic mild cognitive impairment (MCI).

Savaskan E, Summermatter D, Schroeder C, Schächinger H.

PLoS One. 2018 Apr 19;13(4):e0195693. doi: 10.1371/journal.pone.0195693. eCollection 2018.

5.

Recommendations of Swiss Memory Clinics for the Diagnosis of Dementia

Bürge M, Bieri G, Brühlmeier M, Colombo F, Demonet JF, Felbecker A, Georgescu D, Gietl A, Brioschi Guevara A, Jüngling F, Kirsch E, Kressig RW, Kulic L, Monsch AU, Ott M, Pihan H, Popp J, Rampa L, Rüegger-Frey B, Schneitter M, Unschuld PG, von Gunten A, Weinheimer B, Wiest R, Savaskan E.

Praxis (Bern 1994). 2018 Apr;107(8):435-451. doi: 10.1024/1661-8157/a002948. German.

6.

Empfehlungen für Diagnostik und Therapie der Depression im Alter.

Hatzinger M, Hemmeter U, Hirsbrunner T, Holsboer-Trachsler E, Leyhe T, Mall JF, Mosimann U, Rach N, Trächsel N, Savaskan E.

Praxis (Bern 1994). 2018 Jan;107(3):127-144. doi: 10.1024/1661-8157/a002883. Review. German. No abstract available.

PMID:
29382263
7.

Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials.

Savaskan E, Mueller H, Hoerr R, von Gunten A, Gauthier S.

Int Psychogeriatr. 2018 Mar;30(3):285-293. doi: 10.1017/S1041610217001892. Epub 2017 Sep 21. Review.

8.

Best practice in the management of behavioural and psychological symptoms of dementia.

Tible OP, Riese F, Savaskan E, von Gunten A.

Ther Adv Neurol Disord. 2017 Aug;10(8):297-309. doi: 10.1177/1756285617712979. Epub 2017 Jun 19. Review.

9.

Use it or lose it! Cognitive activity as a protec-tive factor for cognitive decline associated with Alzheimer's disease.

Mistridis P, Mata J, Neuner-Jehle S, Annoni JM, Biedermann A, Bopp-Kistler I, Brand D, Brioschi Guevara A, Decrey-Wick H, Démonet JF, Hemmeter U, Kressig RW, Martin B, Rampa L, Savaskan E, Stuck A, Tschopp P, Zekry D, Monsch A.

Swiss Med Wkly. 2017 Mar 1;147:w14407. doi: 10.4414/smw.2017.14407. eCollection 2017. Review.

10.

Hippocampal shape alterations are associated with regional Aβ load in cognitively normal elderly individuals.

Schroeder C, Park MTM, Germann J, Chakravarty MM, Michels L, Kollias S, Kroll SL, Buck A, Treyer V, Savaskan E, Unschuld PG, Nitsch RM, Kälin AM, Hock C, Gietl AF, Leh SE.

Eur J Neurosci. 2017 May;45(10):1241-1251. doi: 10.1111/ejn.13408. Epub 2016 Oct 11.

11.

Empfehlungen zur Prävention, Diagnostik und Therapie des Delirs im Alter.

Savaskan E, Baumgartner M, Georgescu D, Hafner M, Hasemann W, Kressig RW, Popp J, Rohrbach E, Schmid R, Verloo H.

Praxis (Bern 1994). 2016 Aug;105(16):941-52. doi: 10.1024/1661-8157/a002433. Review. German. No abstract available.

PMID:
27524166
12.

[Benzodiazepine Dependency in the Elderly: How to Deal with it].

Savaskan E.

Praxis (Bern 1994). 2016 May 25;105(11):637-41. doi: 10.1024/1661-8157/a002363. Review. German.

PMID:
27223416
13.

Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial.

Forstmeier S, Maercker A, Savaskan E, Roth T.

Trials. 2015 Nov 17;16:526. doi: 10.1186/s13063-015-1043-0.

14.

[Sleep disorders in dementia patients].

Savaskan E.

Z Gerontol Geriatr. 2015 Jun;48(4):312-7. doi: 10.1007/s00391-015-0890-3. Epub 2015 May 9. Review. German.

PMID:
25957245
15.

[Behavioral and psychological symptoms of dementia (BPSD): how to proceed].

Savaskan E.

Ther Umsch. 2015 Apr;72(4):255-60. doi: 10.1024/0040-5930/a000673. Review. German.

PMID:
25791049
16.

[Phytotherapy in geriatrics and gerontology].

Saller R, Kasper S, Dimpfel W, Savaskan E, Pfister T, Rostock M, Witt C, Thuile C, Das O, Unger M.

Forsch Komplementmed. 2014;21 Suppl 1:2-18. doi: 10.1159/000362393. Epub 2014 Jul 4. German. No abstract available.

17.

[Recommendations for diagnosis and therapy of behavioral and psychological symptoms in dementia (BPSD)].

Savaskan E, Bopp-Kistler I, Buerge M, Fischlin R, Georgescu D, Giardini U, Hatzinger M, Hemmeter U, Justiniano I, Kressig RW, Monsch A, Mosimann UP, Mueri R, Munk A, Popp J, Schmid R, Wollmer MA.

Praxis (Bern 1994). 2014 Jan 29;103(3):135-48. doi: 10.1024/1661-8157/a001547. Review. German.

PMID:
24468453
18.

Intranasal insulin increases regional cerebral blood flow in the insular cortex in men independently of cortisol manipulation.

Schilling TM, Ferreira de Sá DS, Westerhausen R, Strelzyk F, Larra MF, Hallschmid M, Savaskan E, Oitzl MS, Busch HP, Naumann E, Schächinger H.

Hum Brain Mapp. 2014 May;35(5):1944-56. doi: 10.1002/hbm.22304. Epub 2013 Aug 1.

PMID:
23907764
19.

[Delirium and multimorbidity in the elderly].

Savaskan E.

Praxis (Bern 1994). 2012 Dec 12;101(25):1633-6. doi: 10.1024/1661-8157/a001147. Review. German.

PMID:
23233102
20.

Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes.

Leuner K, Schulz K, Schütt T, Pantel J, Prvulovic D, Rhein V, Savaskan E, Czech C, Eckert A, Müller WE.

Mol Neurobiol. 2012 Aug;46(1):194-204. doi: 10.1007/s12035-012-8300-y. Epub 2012 Jul 22. Review.

PMID:
22821186
21.

[The emotional memory in the elderly and depression].

Savaskan E.

Praxis (Bern 1994). 2010 Dec 15;99(25):1565-8. doi: 10.1024/1661-8157/a000333. Review. German.

PMID:
21157724
22.

The circadian rest-activity cycle in Korsakoff psychosis.

Wirz-Justice A, Schröder CM, Gasio PF, Cajochen C, Savaskan E.

Am J Geriatr Psychiatry. 2010 Jan;18(1):33-41. doi: 10.1097/JGP.0b013e3181b0467a.

PMID:
19910886
23.

Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice.

Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H, Dröse S, Brandt U, Savaskan E, Czech C, Götz J, Eckert A.

Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20057-62. doi: 10.1073/pnas.0905529106. Epub 2009 Nov 6.

24.

Melatonin reduces arousal and startle responsiveness without influencing startle habituation or affective startle modulation in young women.

Schachinger H, Blumenthal TD, Richter S, Savaskan E, Wirz-Justice A, Kräuchi K.

Horm Behav. 2008 Aug;54(2):258-62. doi: 10.1016/j.yhbeh.2008.03.013. Epub 2008 Apr 10.

PMID:
18499110
25.

Post-learning intranasal oxytocin modulates human memory for facial identity.

Savaskan E, Ehrhardt R, Schulz A, Walter M, Schächinger H.

Psychoneuroendocrinology. 2008 Apr;33(3):368-74. doi: 10.1016/j.psyneuen.2007.12.004. Epub 2008 Jan 24.

PMID:
18221838
26.

Antidepressive therapy with escitalopram improves mood, cognitive symptoms, and identity memory for angry faces in elderly depressed patients.

Savaskan E, Müller SE, Böhringer A, Schulz A, Schächinger H.

Int J Neuropsychopharmacol. 2008 May;11(3):381-8. Epub 2007 Aug 13.

27.

Detection of the human GPR50 orphan seven transmembrane protein by polyclonal antibodies mapping different epitopes.

Hamouda HO, Chen P, Levoye A, Sözer-Topçular N, Daulat AM, Guillaume JL, Ravid R, Savaskan E, Ferry G, Boutin JA, Delagrange P, Jockers R, Maurice P.

J Pineal Res. 2007 Aug;43(1):10-5.

PMID:
17614830
28.

The MT2 melatonin receptor subtype is present in human retina and decreases in Alzheimer's disease.

Savaskan E, Jockers R, Ayoub M, Angeloni D, Fraschini F, Flammer J, Eckert A, Müller-Spahn F, Meyer P.

Curr Alzheimer Res. 2007 Feb;4(1):47-51.

PMID:
17316165
29.

Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease.

Brunner P, Sözer-Topcular N, Jockers R, Ravid R, Angeloni D, Fraschini F, Eckert A, Müller-Spahn F, Savaskan E.

Eur J Histochem. 2006 Oct-Dec;50(4):311-6.

30.

[Melatonin in the elderly and Alzheimer's disease].

Savaskan E.

Praxis (Bern 1994). 2006 Nov 22;95(47):1837-9. German. No abstract available.

PMID:
17168080
31.

Humour therapy in patients with late-life depression or Alzheimer's disease: a pilot study.

Walter M, Hänni B, Haug M, Amrhein I, Krebs-Roubicek E, Müller-Spahn F, Savaskan E.

Int J Geriatr Psychiatry. 2007 Jan;22(1):77-83.

PMID:
16977676
32.

Are G protein-coupled receptor heterodimers of physiological relevance?--Focus on melatonin receptors.

Levoye A, Jockers R, Ayoub MA, Delagrange P, Savaskan E, Guillaume JL.

Chronobiol Int. 2006;23(1-2):419-26. Review.

PMID:
16687315
33.

Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine.

Savaskan E, Schnitzler C, Schröder C, Cajochen C, Müller-Spahn F, Wirz-Justice A.

Int J Neuropsychopharmacol. 2006 Oct;9(5):507-16. Epub 2005 Sep 5.

34.

The role of the brain renin-angiotensin system in neurodegenerative disorders.

Savaskan E.

Curr Alzheimer Res. 2005 Jan;2(1):29-35. Review.

PMID:
15977987
35.

Immunohistochemical Localization of Fas-associated phosphatase-1 (FAP-1) in Alzheimer disease hippocampus.

Savaskan E, Ravid R, Meier F, Müller-Spahn F, Jockers R.

Appl Immunohistochem Mol Morphol. 2005 Jun;13(2):190-3.

PMID:
15894934
36.

Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues.

Savaskan E, Löffler KU, Meier F, Müller-Spahn F, Flammer J, Meyer P.

Ophthalmic Res. 2004 Nov-Dec;36(6):312-20.

37.

Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.

Savaskan E, Ayoub MA, Ravid R, Angeloni D, Fraschini F, Meier F, Eckert A, Müller-Spahn F, Jockers R.

J Pineal Res. 2005 Jan;38(1):10-6.

PMID:
15617532
38.

Orexins and their receptors in the human retina.

Savaskan E, Müller-Spahn F, Meier F, Wirz-Justice A, Meyer P.

Pathobiology. 2004;71(4):211-6. Erratum in: Pathobiology. 2004;71(6):322.

39.

Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity.

Savaskan E, Olivieri G, Meier F, Seifritz E, Wirz-Justice A, Müller-Spahn F.

Gerontology. 2003 Nov-Dec;49(6):380-3.

40.

Beta-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells: influence of the antioxidant melatonin.

Olivieri G, Otten U, Meier F, Baysang G, Dimitriades-Schmutz B, Müller-Spahn F, Savaskan E.

Neuroscience. 2003;120(3):659-65.

PMID:
12895507
41.

Colour vision deficiencies in Alzheimer's disease.

Pache M, Smeets CH, Gasio PF, Savaskan E, Flammer J, Wirz-Justice A, Kaiser HJ.

Age Ageing. 2003 Jul;32(4):422-6.

PMID:
12851187
42.

Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly.

Fontana Gasio P, Kräuchi K, Cajochen C, Someren Ev, Amrhein I, Pache M, Savaskan E, Wirz-Justice A.

Exp Gerontol. 2003 Jan-Feb;38(1-2):207-16.

PMID:
12543279
43.

Skill learning in patients with moderate Alzheimer's disease: a prospective pilot-study of waltz-lessons.

Rösler A, Seifritz E, Kräuchi K, Spoerl D, Brokuslaus I, Proserpi SM, Gendre A, Savaskan E, Hofmann M.

Int J Geriatr Psychiatry. 2002 Dec;17(12):1155-6.

PMID:
12461765
44.

Melatonin MT-1-receptor immunoreactivity in the human eye.

Meyer P, Pache M, Loeffler KU, Brydon L, Jockers R, Flammer J, Wirz-Justice A, Savaskan E.

Br J Ophthalmol. 2002 Sep;86(9):1053-7.

45.

The effects of beta-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion.

Olivieri G, Novakovic M, Savaskan E, Meier F, Baysang G, Brockhaus M, Müller-Spahn F.

Neuroscience. 2002;113(4):849-55.

PMID:
12182891
46.

Oxidative stress modulates tyrosine kinase receptor A and p75 receptor (low-affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cells.

Olivieri G, Otten U, Meier F, Baysang G, Dimitriades-Schmutz B, Müller-Spahn F, Savaskan E.

Neurol Clin Neurophysiol. 2002;2002(2):2-10.

PMID:
12028822
47.

Decline in long-term circadian rest-activity cycle organization in a patient with dementia.

Werth E, Savaskan E, Knoblauch V, Gasio PF, van Someren EJ, Hock C, Wirz-Justice A.

J Geriatr Psychiatry Neurol. 2002 Spring;15(1):55-9.

PMID:
11936245
48.

Distribution of melatonin MT1 receptor immunoreactivity in human retina.

Savaskan E, Wirz-Justice A, Olivieri G, Pache M, Kräuchi K, Brydon L, Jockers R, Müller-Spahn F, Meyer P.

J Histochem Cytochem. 2002 Apr;50(4):519-26.

PMID:
11897804
49.

Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients.

Savaskan E, Olivieri G, Meier F, Brydon L, Jockers R, Ravid R, Wirz-Justice A, Müller-Spahn F.

J Pineal Res. 2002 Jan;32(1):59-62.

PMID:
11841602
50.

Melatonin protects SHSY5Y neuroblastoma cells from cobalt-induced oxidative stress, neurotoxicity and increased beta-amyloid secretion.

Olivieri G, Hess C, Savaskan E, Ly C, Meier F, Baysang G, Brockhaus M, Müller-Spahn F.

J Pineal Res. 2001 Nov;31(4):320-5.

PMID:
11703561

Supplemental Content

Loading ...
Support Center